Americas · News · Toronto Star
VIVUS Announces Positive Outcome of European Procedure to Extend QSIVA® (Phentermine/Topiramate MR) to Adolescents with Obesity
Landmark European approval will grant young patients and families an evidence-based therapy alongside lifestyle interventions ...
Read the full article on Toronto Star Sign in to saveMediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.thestar.com)


